This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Casey, R. G Articles by Bouchier-Hayes, D. J Search for Related Content PubMed PubMed Citation Articles by Casey, R. G Articles by Bouchier-Hayes, D. J Social Bookmarking                         What's this?

Two-week treatment with pravastatin improves ventriculo-vascular haemodynamic interactions in young men with type 1 diabetes

Department of Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

Myles Joyce

Department of Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

Kevin Moore

Department of Endocrinology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

Chris Thompson

Department of Endocrinology, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

Patricia Fitzgerald

Non-invasive Vascular Laboratory, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

David J Bouchier-Hayes

Department of Surgery, Beaumont Hospital, Beaumont Road, Dublin 9, Ireland.

Young patients with diabetes but without established vascular disease have altered conduit and resistance artery reactivity. Early endothelial dysfunction is an initial step in atherogenesis: reductions in nitric oxide (NO) production in these vascular beds are implicated.

The study aim was two-fold: first, to detect baseline abnormalities in cardiac function, conduit vessels and the microcirculation using applanation tonometry, brachial artery ultrasound and laser Doppler fluximetry, respectively; and second, to investigate any modification in these parameters with the use of pravastatin.

Nine young men with diabetes and normoalbuminuria were randomised in a double-blind cross-over fashion to placebo or pravastatin (40 mg) treatment for two weeks. They underwent scans on three separate occasions. Control patients (n=12) underwent a baseline scan but were not given any drug treatment.

It was found that patients with diabetes had significantly higher systolic and diastolic blood pressures, heart rate and Buckberg index (propensity to myocardial ischaemia). Brachial artery reactivity and microcirculatory dilation were both reduced. Levels of von Willebrand Factor, a marker of endothelial damage, were also elevated. Pravastatin treatment restored these sub-clinical abnormalities towards normal levels.

In conclusion, pravastatin improves vascular abnormalities in young male patients with diabetes through alterations in microcirculation and conduit vessel function, with secondary myocardial effects. This may be of benefit in preventing end-organ injury.

Key Words: applanation tonometry • flow-mediated dilatation (FMD) • laser Doppler fluximetry • diabetes • von Willebrand Factor • pravastatin

Diabetes and Vascular Disease Research, Vol. 4, No. 1, 53-61 (2007)
DOI: 10.3132/dvdr.2007.007


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?